118 related articles for article (PubMed ID: 32703490)
21. Oxidative stress enhances tumorigenicity and stem-like features via the activation of the Wnt/β-catenin/MYC/Sox2 axis in ALK-positive anaplastic large-cell lymphoma.
Wu C; Gupta N; Huang YH; Zhang HF; Alshareef A; Chow A; Lai R
BMC Cancer; 2018 Apr; 18(1):361. PubMed ID: 29609590
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-101 Inhibits Growth, Proliferation and Migration and Induces Apoptosis of Breast Cancer Cells by Targeting Sex-Determining Region Y-Box 2.
Wang J; Zeng H; Li H; Chen T; Wang L; Zhang K; Chen J; Wang R; Li Q; Wang S
Cell Physiol Biochem; 2017; 43(2):717-732. PubMed ID: 28946143
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway.
Mohammadi-Yeganeh S; Paryan M; Arefian E; Vasei M; Ghanbarian H; Mahdian R; Karimipoor M; Soleimani M
Tumour Biol; 2016 Jul; 37(7):8993-9000. PubMed ID: 26758430
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-9501 inhibits breast cancer proliferation and metastasis through regulating Wnt/β-catenin pathway.
Que LM; Yang XR; Zhang YC; Zhong H
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4337-4347. PubMed ID: 32373971
[TBL] [Abstract][Full Text] [Related]
25. UPK1B promotes the invasion and metastasis of bladder cancer via regulating the Wnt/β-catenin pathway.
Wang FH; Ma XJ; Xu D; Luo J
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5471-5480. PubMed ID: 30229818
[TBL] [Abstract][Full Text] [Related]
26. GALNT14 in association with GDF-15 promotes stemness and drug resistance through β-catenin signalling pathway in breast cancer.
Gadwal A; Purohit P; Khokhar M; Vishnoi JR; Pareek P; Choudhary R; Elhence P; Banerjee M; Sharma P
Mol Biol Rep; 2024 May; 51(1):691. PubMed ID: 38796671
[TBL] [Abstract][Full Text] [Related]
27. CDK12 Promotes Breast Cancer Progression and Maintains Stemness by Activating c-myc/β -catenin Signaling.
Peng F; Yang C; Kong Y; Huang X; Chen Y; Zhou Y; Xie X; Liu P
Curr Cancer Drug Targets; 2020; 20(2):156-165. PubMed ID: 31744448
[TBL] [Abstract][Full Text] [Related]
28. DCLK1 promotes malignant progression of breast cancer by regulating Wnt/β-Catenin signaling pathway.
Wang YL; Li Y; Ma YG; Wu WY
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9489-9498. PubMed ID: 31773701
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-100 suppresses the migration and invasion of breast cancer cells by targeting FZD-8 and inhibiting Wnt/β-catenin signaling pathway.
Jiang Q; He M; Guan S; Ma M; Wu H; Yu Z; Jiang L; Wang Y; Zong X; Jin F; Wei M
Tumour Biol; 2016 Apr; 37(4):5001-11. PubMed ID: 26537584
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-296 functions as a tumor suppressor in breast cancer by targeting FGFR1 and regulating the Wnt/β-catenin signaling pathway.
Sun WM; Tao W; Li JC; Zhu DM; Miao Y
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10422-10432. PubMed ID: 31841196
[TBL] [Abstract][Full Text] [Related]
31. Regulation of NEAT1/miR-214-3p on the growth, migration and invasion of endometrial carcinoma cells.
Wang J; Zhao X; Guo Z; Ma X; Song Y; Guo Y
Arch Gynecol Obstet; 2017 Jun; 295(6):1469-1475. PubMed ID: 28447190
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-224 inhibits proliferation and migration of breast cancer cells by down-regulating Fizzled 5 expression.
Liu F; Liu Y; Shen J; Zhang G; Han J
Oncotarget; 2016 Aug; 7(31):49130-49142. PubMed ID: 27323393
[TBL] [Abstract][Full Text] [Related]
33. MiR-454-3p-Mediated Wnt/β-catenin Signaling Antagonists Suppression Promotes Breast Cancer Metastasis.
Ren L; Chen H; Song J; Chen X; Lin C; Zhang X; Hou N; Pan J; Zhou Z; Wang L; Huang D; Yang J; Liang Y; Li J; Huang H; Jiang L
Theranostics; 2019; 9(2):449-465. PubMed ID: 30809286
[TBL] [Abstract][Full Text] [Related]
34. SOX2, a predictor of survival in gastric cancer, inhibits cell proliferation and metastasis by regulating PTEN.
Wang S; Tie J; Wang R; Hu F; Gao L; Wang W; Wang L; Li Z; Hu S; Tang S; Li M; Wang X; Nie Y; Wu K; Fan D
Cancer Lett; 2015 Mar; 358(2):210-219. PubMed ID: 25543086
[TBL] [Abstract][Full Text] [Related]
35. KIF18B promotes hepatocellular carcinoma progression through activating Wnt/β-catenin-signaling pathway.
Yang B; Wang S; Xie H; Wang C; Gao X; Rong Y; Liu Z; Lu Y
J Cell Physiol; 2020 Oct; 235(10):6507-6514. PubMed ID: 32052444
[TBL] [Abstract][Full Text] [Related]
36. Ubiquitin-like modifier activating enzyme 2 promotes cell migration and invasion through Wnt/β-catenin signaling in gastric cancer.
Li J; Sun X; He P; Liu WQ; Zou YB; Wang Q; Meng XW
World J Gastroenterol; 2018 Nov; 24(42):4773-4786. PubMed ID: 30479464
[TBL] [Abstract][Full Text] [Related]
37. Upregulation of SOX2 activated LncRNA PVT1 expression promotes breast cancer cell growth and invasion.
Wang Y; Zhou J; Wang Z; Wang P; Li S
Biochem Biophys Res Commun; 2017 Nov; 493(1):429-436. PubMed ID: 28882595
[TBL] [Abstract][Full Text] [Related]
38. The Long Non-Coding RNA CRNDE Promotes Colorectal Carcinoma Progression by Competitively Binding miR-217 with TCF7L2 and Enhancing the Wnt/β-Catenin Signaling Pathway.
Yu B; Ye X; Du Q; Zhu B; Zhai Q; Li XX
Cell Physiol Biochem; 2017; 41(6):2489-2502. PubMed ID: 28472810
[TBL] [Abstract][Full Text] [Related]
39. Reduced lncRNA Aim enhances the malignant invasion of triple-negative breast cancer cells mainly by activating Wnt/β-catenin/mTOR/PI3K signaling.
Liu L; Yu D; Shi H; Li J; Meng L
Pharmazie; 2017 Oct; 72(10):599-603. PubMed ID: 29441885
[TBL] [Abstract][Full Text] [Related]
40. Down-regulation of lncRNA BLACAT1 inhibits ovarian cancer progression by suppressing the Wnt/β-catenin signaling pathway via regulating miR-519d-3p.
Yang H; Qi Y; Wang XL; Gu JJ; Shi TM
Mol Cell Biochem; 2020 Apr; 467(1-2):95-105. PubMed ID: 32095930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
